By Benjamin Chiou
Date: Thursday 26 Feb 2026
(Sharecast News) - London-listed investment trust Mid Wynd International underperformed the benchmark over its first half but reiterated confidence in its portfolio over 2026 as the stock's discount to net asset value continued to narrow.
| Broker tips: AstraZeneca, Morgan Sindall | 13-Feb-2026 | ShareCast |
| Transaction in Own Shares | 31-Dec-2025 | ShareCast |
| Transaction in Own Shares | 30-Dec-2025 | ShareCast |
| Transaction in Own Shares | 23-Dec-2025 | ShareCast |
| Broker tips: AstraZeneca, Morgan Sindall | 13-Feb-2026 | 14:11 | PR Newswire |
| Transaction in Own Shares | 31-Dec-2025 | 12:59 | RNS |
| Transaction in Own Shares | 30-Dec-2025 | 16:56 | RNS |
| Transaction in Own Shares | 23-Dec-2025 | 16:39 | RNS |
| Insider Transactions | 16-Jan-2006 | Chicago Tribune |
No recent information was found.
No recent information was found.
| Currency | UK Pounds |
| Share Price | 722.00p |
| Change Today | 2.00p |
| % Change | 0.28 % |
| 52 Week High | 796.00 |
| 52 Week Low | 686.00 |
| Volume | 23,408 |
| Shares Issued | 28.87m |
| Market Cap | £208.43m |
| Beta | 0.00 |
| RiskGrade | 89 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Latest | Previous | |
|---|---|---|
| Interim | Final | |
| Ex-Div | 05-Mar-26 | 09-Oct-25 |
| Paid | 27-Mar-26 | 07-Nov-25 |
| Amount | 3.85p | 4.50p |
| Time | Volume / Share Price |
| 16:35 | 292 @ 722.00p |
| 16:35 | 2,312 @ 722.00p |
| 16:35 | 351 @ 722.00p |
| 16:35 | 217 @ 722.00p |
| 16:35 | 88 @ 722.00p |
You are here: research